Canaccord Adams Said Novo Approval Is Negative for Amylin (AMLN) Jan 26, 2010 09:22AM
David Moenning’s Daily State of the Markets: 7/22 Jul 22, 2009 09:28AM
Canaccord Adams Downgrades Amylin Pharmaceuticals (AMLN) to Sell Jan 28, 2009 11:37AM
David Moenning's Daily State of the Markets: 1/28 Jan 28, 2009 10:18AM
Canaccord Adams Maintains 'Hold' Rating on Amylin Pharmaceuticals (AMLN), Lowers Price Target Nov 11, 2008 11:02AM


Oct 7, 2008 10:56AM Canaccord Adams Upgrades Amylin Pharmaceuticals (AMLN) to Hold; Competitors on the Way and Safety Issues May Continue to Weigh on Shares
Sep 2, 2008 11:40AM Canaccord Adams Reiterates Sell on Amylin (AMLN)
Aug 27, 2008 01:00PM Wall Street Throws In the Towel On Amylin (AMLN) Following New Byetta Patient Deaths
Aug 27, 2008 10:42AM Canaccord Adams Lowers Price Target on Amylin (AMLN) to $20
Aug 19, 2008 12:53PM Canaccord Reiterates Sell on Amylin (AMLN) Following Byetta Issues